Bone News and Research

RSS

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

UAB surgeons perform second toe-to-thumb transplant

Cary Ramey has the word Carpe tattooed on the underside of his right wrist and Diem tattooed on the left. He loves extreme sports, especially mountain biking and "rock climbing without the ropes."

21 Sep 2011

African-American men living in low sunlight areas more likely to have Vitamin D deficiency

African-American men living in areas with low sunlight are up to 3 - times more likely to have Vitamin D deficiency than Caucasian men and should take high levels of Vitamin D supplements, according to a new study from Northwestern University Feinberg School of Medicine.

21 Sep 2011

Risk factors for variety of complications following spine surgery

In the last 20 years, due to diagnostic and surgical advances, more and more patients have become appropriate candidates for spine surgery, and the number of these procedures performed has risen significantly. While medical experts acknowledge the potential benefits of spine surgery, they also understand that complications can reduce the success in the short and long term.

21 Sep 2011

Researchers can reverse aging process for human adult stem cells

Researchers have shown they can reverse the aging process for human adult stem cells, which are responsible for helping old or damaged tissues regenerate.

21 Sep 2011

Vigorous exercise results in stronger bones, reduced diabetes risk and less visceral fat

Cells in bone, fat and the pancreas appear to be talking to each other and one thing they likely are saying is, "Get moving."

20 Sep 2011

New research has potential to alleviate side effects of cancer treatments

Beth Faiman MSN, CNP, a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects for people with blood and bone marrow cancers.

20 Sep 2011

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.

20 Sep 2011

Scientists pioneer new combination treatment for prostate cancer

Scientists at Queen's University have pioneered a new combination treatment for prostate cancer. The treatment, which has been successful in phase one of trials, will now be tested for efficacy in a second phase.

20 Sep 2011

NovaSterilis awarded patent for novel preparation and sterilization of ‘Green State’ devices

NovaSterilis Inc. has been granted US Patent No 7,988,892. The patent, dated August 2, 2011 is entitled “Preparation and Sterilization of Green State Devices Using a Supercritical Fluid Sterilant.”

19 Sep 2011

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.

19 Sep 2011

Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

Tarsa Therapeutics today reported that it presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

19 Sep 2011

NPS announces data about hypoparathyroidism to be presented at ASBMR 2011 meeting

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced that data about hypoparathyroidism will be presented at the 2011 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in San Diego, CA, September 16-20, 2011.

19 Sep 2011

OU student to receive 2011 EPA's STAR Fellowship for research on safe drinking water

A University of Oklahoma environmental science graduate student is the recipient of the 2011 EPA Science to Achieve Results Fellowship for research on safe drinking water with a focus on the Rift Valley area of Ethiopia.

19 Sep 2011

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

19 Sep 2011

Coulter Foundation awards University of Pittsburgh $3.54M grant for translational bioengineering research

The Swanson School of Engineering at the University of Pittsburgh has received a $3.54 million grant from the Wallace H. Coulter Foundation.

17 Sep 2011

Novartis reports positive results from first pivotal ACZ885 Phase III trial in systemic juvenile idiopathic arthritis

Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.

17 Sep 2011

Good absorption of calcium linked to prostate cancer

A study by epidemiologists at Wake Forest Baptist Medical Center and colleagues suggests that a high intake of calcium causes prostate cancer among African-American men who are genetically good absorbers of the mineral.

17 Sep 2011

Simple strategies prevent bloodstream infections and save hundreds of patient lives

Following some basic rules of central line hygiene and maintenance, Johns Hopkins Children's Center and 87 other pediatric hospitals have, over five years, saved hundreds of patient lives and more than $100 million by preventing nearly 3,000 central line bloodstream infections, hospital officials announced on Monday, Sept. 12.

16 Sep 2011

Bone News and Research

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

Clinical trial to evaluate TAU's stem cell technology for ALS

UAB surgeons perform second toe-to-thumb transplant

African-American men living in low sunlight areas more likely to have Vitamin D deficiency

Risk factors for variety of complications following spine surgery

Researchers can reverse aging process for human adult stem cells

Vigorous exercise results in stronger bones, reduced diabetes risk and less visceral fat

New research has potential to alleviate side effects of cancer treatments

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

Scientists pioneer new combination treatment for prostate cancer

NovaSterilis awarded patent for novel preparation and sterilization of ‘Green State’ devices

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

NPS announces data about hypoparathyroidism to be presented at ASBMR 2011 meeting

OU student to receive 2011 EPA's STAR Fellowship for research on safe drinking water

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Coulter Foundation awards University of Pittsburgh $3.54M grant for translational bioengineering research

Novartis reports positive results from first pivotal ACZ885 Phase III trial in systemic juvenile idiopathic arthritis

Good absorption of calcium linked to prostate cancer

Simple strategies prevent bloodstream infections and save hundreds of patient lives

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News